Share price of Aurobindo Pharma rises as Nifty strengthens

The share price of Aurobindo Pharma rises as Nifty strengthens

Aurobindo Pharma Limited is a pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India. Shares of Aurobindo Pharma Ltd. gained 3.32 percent to Rs. 997.6 in Tuesday’s trade as of 10:10 AM (IST). The stock hit a high price of Rs. 1006.1 and low of Rs. 975.05 during the session.

Moreover, the return on equity (ROE) for the stock stood at 16.84 percent. Traded volume on the counter stood at 10:10 AM shares and turnover at Rs. 9.56 crore around that time. The stock of Aurobindo Pharma Ltd. quoted a 52-week high price of Rs. 1023.1 and 52-week low prices of Rs. 525.05, respectively.

The stock’s Beta value, which measures its volatility in relation to the broader market, stood at 1.06.

Promotor/FII Holding;

Promoters held a 48.86 percent stake in the company as of 31-March-2021. While overseas investors held 24.37 percent and domestic institutional investors has 8.84 percent.

Key Financials;

The company reported consolidated sales of Rs. 6498.31 crore for the quarter ended 31-Dec-2020. While down 0.59 percent from the previous quarter’s Rs. 6537.19 crore and down 9.66 percent from the year-ago quarter’s Rs. 5925.93 crore. Net profit after tax for the latest quarter stood at Rs. 2846.46 crore, up 317.67 percent from the same quarter a year ago.

Technicals;

The MACD signaled a bullish bias on the counter. The MACD is known for signaling trend reversals in traded securities or indices. While it is the difference between the 26-day and 12-day exponential moving averages. A nine-day exponential moving average called the signal line, is plotted on top of the MACD to reflect “buy” or “sell” opportunities. When the MACD crosses below the signal line, it gives a bearish signal, indicating that the price of the security may see a downward movement and vice versa.

The post Share price of Aurobindo Pharma rises as Nifty strengthens appeared first on Stock Investor.

Original Article

Published
Categorized as Stock